The forecasted mortality rates for trachea, bronchus, or lung malignant neoplasms in Canada display a declining trend from 2024 to 2028. The rates decrease from 51.8 deaths per hundred thousand persons in 2024 to 50.9 by 2028. This trend indicates a gradual year-on-year reduction in mortality, with an approximate annual rate of -0.4%. Cumulatively over the five-year forecast period, this results in a compound annual growth rate (CAGR) of approximately -0.44%. As of 2023, the mortality rate stood at a higher level, accentuating the effectiveness of ongoing health interventions.
Future trends to watch include advancements in medical technologies, early detection programs, and tobacco control measures, which could further accelerate the decline. Monitoring the introduction and dissemination of new therapies, public health policies, and population health initiatives will be crucial in predicting future mortality patterns in Canada.
